3/10
11:02 am
capr
Capricor Therapeutics (CAPR) had its "buy" rating reaffirmed by HC Wainwright. They now have a $60.00 price target on the stock.
Medium
Report
Capricor Therapeutics (CAPR) had its "buy" rating reaffirmed by HC Wainwright. They now have a $60.00 price target on the stock.
1/14
08:42 am
capr
Capricor Therapeutics (NASDAQ:CAPR) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Capricor Therapeutics (NASDAQ:CAPR) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.